Evidence map›Paper›PMID 39277846›Full record

ArticleHuman molecular genetics2024

Pathomechanisms of Monoallelic variants in TTN causing skeletal muscle disease.

Jochen Gohlke, Johan Lindqvist, Zaynab Hourani, Sarah Heintzman, Paola Tonino, Bakri Elsheikh, Ana Morales, Matteo Vatta, Arthur Burghes, Henk Granzier and 1 more

Erratum issuedAbstract read
In one paragraph

Article in Human molecular genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Phenotype-specific muscle proteomic profiling in titinopathies.Acta neuropathologica communications · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Jochen GohlkeDepartment of Cellular and Molecular Medicine, University of Arizona, 1656 E. Mabel St., Tucson, AZ 85724, United States.
Johan LindqvistDepartment of Cellular and Molecular Medicine, University of Arizona, 1656 E. Mabel St., Tucson, AZ 85724, United States.
Zaynab HouraniDepartment of Cellular and Molecular Medicine, University of Arizona, 1656 E. Mabel St., Tucson, AZ 85724, United States.
Sarah HeintzmanDepartment of Neurology, The Ohio State University Wexner Medical Center, 395 W. 12th Ave, Columbus, OH 43210, United States.
Paola ToninoResearch, Innovation and Impact Core Facilities Department, University of Arizona, 1333 N. Martin Ave, Tucson, AZ 85719, United States.
Bakri ElsheikhDepartment of Neurology, The Ohio State University Wexner Medical Center, 395 W. 12th Ave, Columbus, OH 43210, United States.
Ana MoralesInvitae Corporation, 1400 16th St., San Francisco, CA 94103, United States.
Matteo VattaInvitae Corporation, 1400 16th St., San Francisco, CA 94103, United States.
Arthur BurghesDepartment of Biological Chemistry and Pharmacology, The Ohio State University Wexner Medical Center, 370 W 9th Ave, Columbus, OH 43210, United States.
Henk GranzierDepartment of Cellular and Molecular Medicine, University of Arizona, 1656 E. Mabel St., Tucson, AZ 85724, United States.
Jennifer RoggenbuckDepartment of Neurology, The Ohio State University Wexner Medical Center, 395 W. 12th Ave, Columbus, OH 43210, United States.ORCID 0000-0002-6583-9996

Funding

Role of the giant protein titin in cardiac health and diseaseR35HL144998 · NHLBI · UNIVERSITY OF ARIZONA · PI GRANZIER, HENK L. · 2019 to 2025
$6.3M
Titin-based stiffness regulation and mechanosensing in activated skeletal muscle.R01AR083233 · NIAMS · UNIVERSITY OF ARIZONA · PI Henk L. GRANZIER · 2023 to 2026
$2.4M
NHLBI NIH HHS R35 HL144998NIAMS NIH HHS R01 AR083233NIH HHS R01AR083233
6 · The paper itself

Abstract

Pathogenic variants in the titin gene (TTN) are known to cause a wide range of cardiac and musculoskeletal disorders, with skeletal myopathy mostly attributed to biallelic variants. We identified monoallelic truncating variants (TTNtv), splice site or internal deletions in TTN in probands with mild, progressive axial and proximal weakness, with dilated cardiomyopathy frequently developing with age. These variants segregated in an autosomal dominant pattern in 7 out of 8 studied families. We investigated the impact of these variants on mRNA, protein levels, and skeletal muscle structure and function. Results reveal that nonsense-mediated decay likely prevents accumulation of harmful truncated protein in skeletal muscle in patients with TTNtvs. Splice variants and an out-of-frame deletion induce aberrant exon skipping, while an in-frame deletion produces shortened titin with intact N- and C-termini, resulting in disrupted sarcomeric structure. All variant types were associated with genome-wide changes in splicing patterns, which represent a hallmark of disease progression. Lastly, RNA-seq studies revealed that GDF11, a member of the TGF-β superfamily, is upregulated in diseased tissue, indicating that it might be a useful therapeutic target in skeletal muscle titinopathies.

Indexed as

ConnectinMuscle, SkeletalMuscular DiseasesAdultAllelesCardiomyopathy, DilatedFemaleGrowth Differentiation FactorsHumansMaleMiddle AgedMutationPedigreeRNA SplicingConnectinGrowth Differentiation FactorsTTN protein, humanDominant titinopathyTitintitinopathy pathomechanismsTTN deletionTTNtv

Identifiers

PMID39277846
PMCPMC11578113

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.